Lawsuit Alleges Similac Caused NEC Injury After Mother Advised Not to Breastfeed Newborn
A Similac Neosure lawsuit filed by a Massachusetts couple claims the use of the cow's milk-based infant formula led to NEC injuries.
Tag Archives: Similac Recall
-
-
Wider Awareness of Cronobacter Infection Risks Needed After Similac Recall: CDC Researchers Warn
A CDC study calls for safer storage and preparation of infant formula products and breast pumps due to the increasing risk of cronobacter infections, such as those linked to a…
-
FDA Withdraws Proposed Food Modernization Plan
The FDA has withdrawn a food safety modernization plan originally proposed in 2005, amid criticism for how it has handled the Similac infant formula recall and resulting shortage.
-
NEC Similac Alimentum Lawsuit Alleges Abbott Failed To Disclose Risk of Severe Intestinal Disease for Newborns
An NEC Similac Alimentum lawsuit claims a preterm child suffered severe intestinal problems caused by consuming the cow's milk-based formula.
-
Similac Recall Class Action Lawsuit Filed Over Contaminated Infant Formula
A Similac recall class action lawsuit claims parents who bought contaminated infant formula should get a full or partial refund.
-
FDA Looks at Reorganizing Its Human Foods Program After Botched Similac Infant Formula Recall
The FDA has announced plans to reorganize its Human Foods Program, with a greater focus on nutrition, and coordination with state and local regulators.
-
Plant Linked to Abbott Infant Formula Recall Under Investigation by DOJ
Abbott officials have confirmed the company's Sturgis, Michigan facility is under criminal investigation over last year's infant formula recall.
-
ByHeart Infant Formula Recall Issued Due to Potential Cronobacter Contamination
-
FDA Food Division Too Afraid of Confronting Industry to Protect Public Health, Review Finds
A new report outlines a host of changes the FDA needs to make to its Human Foods Program to protect public health.
-
In Wake of Similac Recall, FDA Announces Strategy to Keep Cronobacter Out of Infant Formula Products
The FDA has introduced a new strategy outlining how the agency hopes to prevent cronobacter infant infections like those linked to a recent Similac recall.
